Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
AAB-003 PF-05236812 Alzheimer's Disease (Phase 1) Janssen, Pfizer Amyloid-Related Immunotherapy (passive)
LY2599666 Alzheimer's Disease (Phase 1) Eli Lilly & Co. Amyloid-Related Immunotherapy (passive)
LY3002813 N3pG-Aβ Monoclonal Antibody Alzheimer's Disease (Phase 1) Eli Lilly & Co. Amyloid-Related Immunotherapy (passive)
LY3303560 Alzheimer's Disease (Phase 1) Eli Lilly & Co. Unknown Immunotherapy (passive)
MEDI1814 Alzheimer's Disease (Phase 1) Eli Lilly & Co. Amyloid-Related Immunotherapy (passive)
RO 7105705 RG 6100 Alzheimer's Disease (Phase 1) AC Immune SA, Genentech, Hoffmann-La Roche Tau Immunotherapy (passive)
SAR228810 Alzheimer's Disease (Phase 1) Sanofi Amyloid-Related Immunotherapy (passive)